ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome. (1st October 2014)

• Record Type: Journal Article
• Authors: de Biase, Stefano; Merlino, Giovanni; Lorenzut, Simone; Valente, Mariarosaria; Gigli, Gian Luigi
• Is Part Of: Expert opinion on drug metabolism and toxicology. Volume 10:Number 10(2014:Oct.)
• Page Start: 1365
• Page End: 1380
• Publication Date: 2014-10-01
• Subjects: absorption -- augmentation -- distribution -- dopamine -- elimination -- metabolism -- monoamine oxidase B inhibitors -- oxycodone-naloxone -- pharmacokinetic -- toxicology; Drugs -- Toxicology -- Periodicals; Drugs -- Metabolism -- Periodicals; 615.7
• DOI: 10.1517/17425255.2014.952629
• Languages: English
• ISSNs: 1742-5255

Abstract

Abstract : Introduction: Restless legs syndrome (RLS) is a commonly occurring sensory motor disorder that might impair nocturnal rest causing decreased alertness, depression, reduced job performance and poor quality of life. In patients affected by severe RLS, a pharmacological treatment is mandatory. Areas covered: The present review is based on a search using PubMed from 1994 to 2014. It is focused on the Absorption, Distribution, Metabolism, Elimination and Toxicology (ADMET) characteristics of drugs currently used and under development for the treatment of RLS. Expert opinion: The drugs currently available for RLS treatment do not always provide an optimal control of symptoms. There is still need for effective and well-tolerated new drugs. Long-acting dopamine agonists showed better efficacy than short-acting compounds in the treatment of severe RLS. There seems to be an inverse relationship between the half-life of the compound and the development of augmentation. Monoamine oxidase B inhibitors could be good candidates for initial treatment of RLS, sparing stronger dopaminergic agents for later stages of the disease. Oxycodone-naloxone demonstrated a significant and sustained treatment effect for patients with severe RLS insufficiently treated with first-line drugs and could be used as a long-term treatment in severe RLS when alternative satisfactory drug regimens are unavailable.